Prot# GS-US-174-0108: A Phase 2, Double-Blind, Multi-Center, Randomized Study Comparing Tenofovir Disoproxil Fumarate, Emtricitabine + Tenofovir Disoproxil Fumarate, & Entecavir in the Treatment of Chronic Hepatitis B Subjects w/Decompensated

Project: Research project

Project Details

StatusFinished
Effective start/end date8/2/061/1/12

Funding

  • Ingenix Pharmaceutical Services, Inc. (GS-US-174-0108)
  • Gilead Sciences, Inc. (GS-US-174-0108)